Peptides arent stable when used in creams
The research use only model keeps them in the FDAs peripheral vision
In the SURPASS clinical trial program for type 2 diabetes, diarrhea occurred in approximately 12-16% of patients receiving tirzepatide across various doses (5 mg, 10 mg, and 15 mg weekly), compared to lower rates in comparator groups
Oral capsules and tablets should be stored below 25C in opaque, moisture-resistant bottles with desiccant packs
Tirzepatide is a first-in-class T2D medication that activates both the GIP and GLP-1 receptors to help patients better manage blood sugar, while triggering weight loss and improving lipid markers
Mild to severe side effects can occur, and you should report them to your doctor and healthcare team